These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Intravesical bacille Calmette-Guérin versus mitomycin C in superficial bladder cancer: formal meta-analysis of comparative studies on tumor progression. Böhle A; Bock PR Urology; 2004 Apr; 63(4):682-6; discussion 686-7. PubMed ID: 15072879 [TBL] [Abstract][Full Text] [Related]
4. Results of a randomized phase III trial of sequential intravesical therapy with mitomycin C and bacillus Calmette-Guerin versus mitomycin C alone in patients with superficial bladder cancer. Witjes JA; Caris CT; Mungan NA; Debruyne FM; Witjes WP J Urol; 1998 Nov; 160(5):1668-71; discussion 1671-2. PubMed ID: 9783928 [TBL] [Abstract][Full Text] [Related]
5. [Bacillus Calmette Guerin as adjuvant treatment for superficial bladder tumors using two different therapeutic schemes]. Iturralde Codina A; Beyríe Tamayo W; Gozá León F; Muñoz YI Arch Esp Urol; 2004; 57(6):606-18. PubMed ID: 15382436 [TBL] [Abstract][Full Text] [Related]
6. [Intravesical instillation in the treatment of superficial tumors of the bladder]. Chopin DK Prog Urol; 1998 Apr; 8(2):268-73. PubMed ID: 9615941 [TBL] [Abstract][Full Text] [Related]
7. [Superficial bladder cancer: prophylaxis of recurrence and progression]. Miyanaga N; Akaza H; Koiso K Gan To Kagaku Ryoho; 1991 Nov; 18(14):2369-74. PubMed ID: 1719939 [TBL] [Abstract][Full Text] [Related]
8. A multicentre, randomised prospective trial comparing three intravesical adjuvant therapies for intermediate-risk superficial bladder cancer: low-dose bacillus Calmette-Guerin (27 mg) versus very low-dose bacillus Calmette-Guerin (13.5 mg) versus mitomycin C. Ojea A; Nogueira JL; Solsona E; Flores N; Gómez JM; Molina JR; Chantada V; Camacho JE; Piñeiro LM; Rodríguez RH; Isorna S; Blas M; Martínez-Piñeiro JA; Madero R; Eur Urol; 2007 Nov; 52(5):1398-406. PubMed ID: 17485161 [TBL] [Abstract][Full Text] [Related]
9. An individual patient data meta-analysis of the long-term outcome of randomised studies comparing intravesical mitomycin C versus bacillus Calmette-Guérin for non-muscle-invasive bladder cancer. Malmström PU; Sylvester RJ; Crawford DE; Friedrich M; Krege S; Rintala E; Solsona E; Di Stasi SM; Witjes JA Eur Urol; 2009 Aug; 56(2):247-56. PubMed ID: 19409692 [TBL] [Abstract][Full Text] [Related]
10. Clinical study of bladder cancer: Proteinuria as a predictor of recurrence and efficacy of intravesical bacille Calmette-Guerin therapy. Satoh A; Hanawa Y; Nakamura S Int J Urol; 2004 Jul; 11(7):476-82. PubMed ID: 15242355 [TBL] [Abstract][Full Text] [Related]
12. [Results of BCG in the treatment of pTa and pT1 bladder tumors. Evaluation of a long protocol using 75 mg of Pasteur strain BCG]. Ayed M; Ben Hassine L; Ben Slama R; Chelbi N; Ghozzi S; Drissi H; Jemni M; Chebil M Prog Urol; 1998 Apr; 8(2):206-10. PubMed ID: 9615929 [TBL] [Abstract][Full Text] [Related]
13. Bacillus calmette-guerin versus chemotherapy for the intravesical treatment of patients with carcinoma in situ of the bladder: a meta-analysis of the published results of randomized clinical trials. Sylvester RJ; van der Meijden AP; Witjes JA; Kurth K J Urol; 2005 Jul; 174(1):86-91; discussion 91-2. PubMed ID: 15947584 [TBL] [Abstract][Full Text] [Related]
14. Long-term intravesical adjuvant chemotherapy further reduces recurrence rate compared with short-term intravesical chemotherapy and short-term therapy with Bacillus Calmette-Guérin (BCG) in patients with non-muscle-invasive bladder carcinoma. Friedrich MG; Pichlmeier U; Schwaibold H; Conrad S; Huland H Eur Urol; 2007 Oct; 52(4):1123-29. PubMed ID: 17383080 [TBL] [Abstract][Full Text] [Related]
15. Restaging transurethral resection of high risk superficial bladder cancer improves the initial response to bacillus Calmette-Guerin therapy. Herr HW J Urol; 2005 Dec; 174(6):2134-7. PubMed ID: 16280743 [TBL] [Abstract][Full Text] [Related]
16. Can intravesical bacillus Calmette-Guérin reduce recurrence in patients with superficial bladder cancer? A meta-analysis of randomized trials. Han RF; Pan JG Urology; 2006 Jun; 67(6):1216-23. PubMed ID: 16765182 [TBL] [Abstract][Full Text] [Related]